Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05409144
Other study ID # AP2202-30106
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 20, 2022
Est. completion date April 1, 2023

Study information

Verified date June 2022
Source National Cancer Institute, Egypt
Contact Ahmed Abdelfattah, M.Sc
Phone 1222332541
Email Dr.ahmed.sha3ban@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the impact of Ultrasound-guided Erector Spinae plane block compared to Ultrasound-guided serratus anterior plane block on the emergence of post-thoracotomy pain syndrome in patients undergoing lobectomy for lung cancer.


Description:

Lung cancer has the highest incidence of all malignancies worldwide and accounts for approximately 13% of all cancer cases. Lung cancer is still the most common cause of cancer-related deaths, and lung resection surgeries could be the main therapeutic option. Hence, the number of thoracotomy procedures is progressively increasing as is the incidence of post-thoracotomy pain. In addition to amputation and mastectomy, thoracotomy is considered the main etiology of severe and long-term acute and chronic post-surgical pain syndromes (CPSPs). The prevalence of post-thoracotomy pain syndrome (PTPS) is widely variable (30%-50%) and may range from 11% to 80%, according to other studies. The International Association for the Study of Pain (IASP) has defined post-thoracotomy pain syndrome as "pain that recurs or persists along the thoracotomy scar at least 2 months after the procedure". In addition, post-thoracotomy pain syndrome is mostly described with neuropathic manifestations along the thoracotomy scar and in the mammary, inframammary, ipsilateral scapular and interscapular areas. The ultrasound-guided erector spinae plane (ESP) block is a novel technique for thoracic analgesia that promises to be a relatively simple and safe alternative to more complex and invasive techniques of neural blockade.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 111
Est. completion date April 1, 2023
Est. primary completion date April 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age (18-65) Years - Physical status American Society of Anesthesiologists Classification II, III - Patients undergoing lobectomy through lateral thoracotomy - Body mass index (BMI): (20-40) kg/m2 Exclusion Criteria: - Patient refusal. - Age <18 years or >65 years - Body mass index (BMI) <20 kg/m2 and >40 kg/m2 - Known sensitivity or contraindication to drugs used in the study - Contraindication to regional anesthesia e.g. local infection at site of introduction, pre-existing peripheral neuropathies and coagulopathy. - Pregnancy. - Physical status American Society of Anesthesiologists Classification IV - patients on chronic analgesic therapy (daily morphine =30 mg or equivalent dose of other opioids or tramadol or any medication for neuropathic pain) - patients with a history of drug abuse - patients with neuropsychiatric diseases; patients with a history of chronic pain syndromes that may enhance sensitivity to pain, for example, fibromyalgia - patients with a history of thoracic surgery through lateral thoracotomy; and patients with recurrent chest malignancies within 3 months. - All patients who developed severe intra- or post-operative bleeding or required postoperative mechanical ventilation were also excluded from the study. - Thoracic spine disorders or deformity.

Study Design


Intervention

Procedure:
Thoracic epidural infusion
Upon locating the desired site spot, lidocaine 1% must be injected into the skin and underlying tissues to decrease the discomfort with the advancement of the epidural needle. Once achieving local anesthesia, the epidural needle advanced with its stylet in place and with its bevel point cephalad; this will ultimately contribute to the proper location of the epidural catheter. The epidural needle must be advanced through the skin, subcutaneous tissue, supraspinous, and interspinous ligaments. Once there, the stylet must be removed, and the Loss of Resistance syringe (filled up with saline, air, or both) must be attached to the needle. The needle must be advanced while applying pressure to the plunger. Once the ligamentum flavum is pierced, a loss in resistance will be noted; this is the epidural space, and 5 to 10 cc of saline is injected to expand the epidural space; this may decrease the risk of vascular injury.
Device:
Erector Spinae Plane Block
The block-level will be at T5. The ultrasound probe will be placed on the back in a transverse orientation to identify the tip of the T5 transverse process; these are recognizable as flat, squared-off acoustic shadows with only a very faint image of the pleura visible. The tip of the transverse process will be centered on the ultrasound screen and the probe will then be rotated into a longitudinal orientation to produce a parasagittal view, in which the following layers will be visible superficial to the acoustic shadows of the transverse processes: skin and subcutaneous tissue, trapezius, erector spinae muscle and T5 transverse process. 3ml lidocaine 1% will be used on skin and subcutaneous fat, Echogenic block needle will be inserted in-plane to the ultrasound beam in a cranial-to-caudal direction until contact is made with the T5 transverse process.
Serratus Anterior Plane Block
The block is performed with full aseptic precautions. Arm abduction is preferred. The ultrasound probe will be placed on the patient's midaxillary line in the transverse plane, at the level of the fifth rib, with the indicator oriented toward the operator's left. With the rib, pleural line, and overlying serratus anterior and latissimus dorsi muscles visualized, then, 3ml lidocaine 1% will be used for skin and subcutaneous fat, using ultrasound guidance, a 38-mm 22-gauge regional block needle is going to be advanced in-plane at an angle of approximately 45 degrees towards the fifth rib. After aspiration to avoid intravascular injection 30ml of levobupivacaine 0.25% will be injected anteriorly to the rib and deep into the serratus anterior muscle.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
National Cancer Institute, Egypt

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of patients developing post-thoracotomy pain syndrome The incidence of patients developing post-thoracotomy pain syndrome according to grading system for neuropathic pain (GSNP 12 weeks postoperatively
Secondary Morphine consumption The total amount of morphine consumed postoperatively for 48 hours. 48 hours Postoperatively
Secondary Fentanyl consumption Total amount of fentanyl consumed intraoperative Intraoperatively
Secondary Post-thoracotomy pain syndrome severity Severity of Post-thoracotomy pain syndrome according to Grading system for neuropathic pain (GSNP) 12 weeks postoperatively
Secondary Patient's Quality of life Patient's Quality of life according to the Flanagan Quality of Life Scale (QOLS) 12 weeks postoperatively
Secondary Postoperative Patient's activity level Postoperative Patient's activity level according to Barthel Activities of Daily Living scale (ADL) 12 weeks postoperatively
Secondary Heart rate Heart rate will be recorded Intraoperatively
Secondary Mean arterial blood pressure Mean arterial blood pressure will be recorded Intraoperatively
Secondary Nausea and vomiting Postoperative nausea and vomiting (PONV) will be recorded 24 hours postopertivley
Secondary Post-operative pain Post-operative pain will be assessed by the Numeric Rating Scale (NRS) 24 hours postopratively
Secondary Time taken till 1st rescue analgesic request The time till administration of first rescue analgesia will be recorded 24 hours postopratively
Secondary Postoperative pulmonary complications Postoperative pulmonary complications will be recorded 24 hours postopratively
See also
  Status Clinical Trial Phase
Completed NCT04110210 - Effectiveness of Bilateral Ultrasound-Guided Erector Spinae Plane Block Early Phase 1
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Recruiting NCT06088836 - Ultrasound- Guided Continuous Retro Laminar Block Versus Continuous Erector Spinae Plane Block in Multiple Rib Fractures N/A
Recruiting NCT04403360 - Erector Spinae Plane Block After Lumbar Spinal Stenosis Surgery N/A
Completed NCT05625009 - Bilateral Ultrasound-Guided Transversus Abdominis Plane (Tap) Block and Erector Spinal Plane (Esp) Block N/A
Not yet recruiting NCT06127966 - The Relationship Between NLR and PONV and ESPB Phase 1
Completed NCT06143020 - Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction N/A
Recruiting NCT05158270 - Erector Spinae Plane Block As Alternative Analgesic Modality in Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT04845711 - Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block in Laparoscopic Cholecystectomy N/A
Recruiting NCT06377605 - The Efficacy of Thoracic Erector Spinae Plane Block For Perioperative Analgesia in Laparoscopic Bariatric Surgery for Super Obese Patients: Randomized Controlled Trial. N/A
Recruiting NCT06233617 - Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery Phase 4
Not yet recruiting NCT04757480 - Thoracolumbar Interfascial Plane Block Versus Bilateral Erector Spinae Plane Block In Lumbar Laminectomy N/A
Active, not recruiting NCT04474873 - Effectivenes of Erector Spinae Plane Block in Percutaneous Nephrolithotomy? N/A
Recruiting NCT03887260 - Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Nephrectomy/Nephron Sparing Surgery(NSS) Performed Via Lumbotomy N/A
Completed NCT05083832 - Effect of Two Different Plane Blocks on Post-thoracotomy Pain N/A
Completed NCT05121727 - Comparison of Erector Spinae Plane Block and Combination of Deep and Superficial Serratus Anterior Plane Block N/A
Recruiting NCT05970380 - Effect of Erector Spinae Plane Block in Patients Scheduled for Kyphoplasty
Completed NCT03968146 - Erector Spinae Plane Block in Scoliotic Adolescents Phase 2
Not yet recruiting NCT06441071 - Patients' Positions on Analgesic Efficacy of ESPB N/A
Recruiting NCT04420104 - Errector Spinae Plane Block for Postoperative Pain Management in Cardiac Surgery: A Randomized Controlled Trial N/A